What is Relenza (zanamivir)?
Relenza (zanamivir) is a flu medication and an inhaled antiviral drug used to treat and prevent influenza (the “flu”). Relenza decreases the spread of influenza A and B viruses, the viruses responsible for the flu. It does this by blocking the action of neuraminidase, an enzyme produced by the viruses that enables the viruses to spread from infected cells to healthy cells.
By preventing the spread of virus from cell to cell, the symptoms and duration of influenza infection are reduced. On average, Relenza reduces the duration of symptoms by one day if treatment is started within forty-eight hours after symptoms begin.
Common side effects of Relenza include:
Serious side effects of Relenza include:
- increase or decrease in appetite,
- fever,
- chills,
- weakness,
- sinusitis,
- ear/nose/throat infections,
- skin reactions,
- muscle or joint pain,
- allergic reactions,
- bronchospasm,
- behavioral disturbances, and
- breathing problems in patients with respiratory diseases.
Drug interactions of Relenza include injections of live attenuated flu vaccine, because Relenza prevents viral replication.
The Centers for Disease Control (CDC) states that pregnancy is not a contraindication for use of Relenza in pregnant women because the benefits outweigh the risks.
It is unknown if Relenza is excreted in breast milk. However, the CDC recommends that nursing women who develop flu after childbirth should be treated with antiviral drugs. Consult your doctor before breastfeeding.
What are the important side effects of Relenza (zanamivir)?
The most frequent side effects are:
Other important side effects include:
- increase or decrease in appetite,
- fever,
- chills,
- weakness,
- sinusitis, and
- ear; nose; and throat infections,
- skin reactions,
- muscle or joint pain,
- allergic reactions,
- bronchospasm, and
- behavioral disturbances.
Patients with respiratory diseases may experience breathing problems when treated with zanamivir due to irritation of the breathing tubes by the particles from the inhaler. If breathing problems occur, zanamivir should be discontinued. Patients who have asthma or other breathing problems that make them sensitive to inhaled particles should have a fast acting, inhaled bronchodilator available to treat any breathing problem that may occur when zanamivir is used.
Relenza (zanamivir) side effects list for healthcare professionals
See product information about risk of serious adverse events such as bronchospasm and allergic-like reactions, and for safety information in patients with underlying airways disease.
Clinical Trials Experience
Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared with rates in the clinical trials of another drug and may not reflect the rates observed in practice.
The placebo used in clinical trials consisted of inhaled lactose powder, which is also the vehicle for the active drug; therefore, some adverse events occurring at similar frequencies in different treatment groups could be related to lactose vehicle inhalation.
Treatment Of Influenza
Clinical Trials in Adults and Adolescents
Adverse events that occurred with an incidence greater than or equal to 1.5% in treatment trials are listed in Table 1. This table shows adverse events occurring in subjects aged 12 years and older receiving Relenza 10 mg inhaled twice daily, Relenza in all inhalation regimens, and placebo inhaled twice daily (where placebo consisted of the same lactose vehicle used in Relenza).
Table 1. Summary of Adverse Events Greater than or Equal to 1.5% Incidence during Treatment
in Adults and Adolescents
Adverse Event | Relenza | Placebo (Lactose Vehicle) (n = 1,520) |
|
10 mg b.i.d. Inhaled (n = 1,132) |
All Dosing Regimensa (n = 2,289) |
||
Body as a whole | |||
Headaches | 2% | 2% | 3% |
Digestive | |||
Diarrhea | 3% | 3% | 4% |
Nausea | 3% | 3% | 3% |
Vomiting | 1% | 1% | 2% |
Respiratory | |||
Nasal signs and symptoms | 2% | 3% | 3% |
Bronchitis | 2% | 2% | 3% |
Cough | 2% | 2% | 3% |
Sinusitis | 3% | 2% | 2% |
Ear, nose, and throat infections | 2% | 1% | 2% |
Nervous system | |||
Dizziness | 2% | 1% | <1% |
aIncludes trials where Relenza was administered intranasally (6.4 mg 2 to 4 times per day in addition to inhaled preparation) and/or inhaled more frequently (q.i.d.) than the currently recommended dose. |
Additional adverse reactions occurring in less than 1.5% of subjects receiving Relenza included malaise, fatigue, fever, abdominal pain, myalgia, arthralgia, and urticaria.
The most frequent laboratory abnormalities in Phase III treatment trials included elevations of liver enzymes and CPK, lymphopenia, and neutropenia. These were reported in similar proportions of zanamivir and lactose vehicle placebo recipients with acute influenza-like illness.
Clinical Trials in Pediatric Subjects
Adverse events that occurred with an incidence greater than or equal to 1.5% in children receiving treatment doses of Relenza in 2 Phase III trials are listed in Table 2. This table shows adverse events occurring in pediatric subjects aged 5 to 12 years receiving Relenza 10 mg inhaled twice daily and placebo inhaled twice daily (where placebo consisted of the same lactose vehicle used in Relenza).
Table 2. Summary of Adverse Events Greater than or Equal to 1.5% Incidence during Treatment
in Pediatric Subjectsa
Adverse Event | Relenza 10 mg b.i.d. Inhaled (n = 291) |
Placebo (Lactose Vehicle) (n = 318) |
Respiratory | ||
Ear, nose, and throat infections | 5% | 5% |
Ear, nose, and throat hemorrhage | <1% | 2% |
Asthma | <1% | 2% |
Cough | <1% | 2% |
Digestive | ||
Vomiting | 2% | 3% |
Diarrhea | 2% | 2% |
Nausea | <1% | 2% |
aIncludes a subset of subjects receiving Relenza for treatment of influenza in a prophylaxis trial. |
In 1 of the 2 trials described in Table 2, some additional information is available from children (aged 5 to 12 years) without acute influenza-like illness who received an investigational prophylaxis regimen of Relenza; 132 children received Relenza and 145 children received placebo. Among these children, nasal signs and symptoms (zanamivir 20%, placebo 9%), cough (zanamivir 16%, placebo 8%), and throat/tonsil discomfort and pain (zanamivir 11%, placebo 6%) were reported more frequently with Relenza than placebo. In a subset with chronic pulmonary disease, lower respiratory adverse events (described as asthma, cough, or viral respiratory infections which could include influenza-like symptoms) were reported in 7 of 7 zanamivir recipients and 5 of 12 placebo recipients.
Prophylaxis Of Influenza
Family/Household Prophylaxis Studies
Adverse events that occurred with an incidence of greater than or equal to 1.5% in the 2 prophylaxis trials are listed in Table 3. This table shows adverse events occurring in subjects aged 5 years and older receiving Relenza 10 mg inhaled once daily for 10 days.
Table 3. Summary of Adverse Events Greater than or Equal to 1.5% Incidence during 10-Day
Prophylaxis Trials in Adults, Adolescents, and Childrena
Adverse Event | Contact Cases | |
Relenza (n = 1,068) |
Placebo (n = 1,059) |
|
Lower respiratory | ||
Viral respiratory infections | 13% | 19% |
Cough | 7% | 9% |
Neurologic | ||
Headaches | 13% | 14% |
Ear, nose, and throat | ||
Throat and tonsil discomfort and pain | 8% | 9% |
Nasal signs and symptoms | 12% | 12% |
Nasal inflammation | 1% | 2% |
Mus culos keletal | ||
Muscle pain | 3% | 3% |
Endocrine and metabolic | ||
Feeding problems (decreased or increased appetite and anorexia) | 2% | 2% |
Gastrointestinal | ||
Nausea and vomiting | 1% | 2% |
Non-site specific | ||
Malaise and fatigue | 5% | 5% |
Temperature regulation disturbances (fever and/or chills) | 5% | 4% |
aIn prophylaxis trials, symptoms associated with influenza-like illness were captured as adverse events; subjects were enrolled during a winter respiratory season during which time any symptoms that occurred were captured as adverse events. |
Community Prophylaxis Trials
Adverse events that occurred with an incidence of greater than or equal to 1.5% in 2 prophylaxis trials are listed in Table 4. This table shows adverse events occurring in subjects aged 5 years and older receiving Relenza 10 mg inhaled once daily for 28 days.
Table 4. Summary of Adverse Events Greater than or Equal to 1.5% Incidence during 28-Day
Prophylaxis Trials in Adults, Adolescents, and Childrena
Adverse Event | Relenza (n = 2,231) |
Placebo (n = 2,239) |
Neurologic | ||
Headaches | 24% | 26% |
Ear, nose, and throat | ||
Throat and tonsil discomfort and pain | 19% | 20% |
Nasal signs and symptoms | 12% | 13% |
Ear, nose, and throat infections | 2% | 2% |
Lower respiratory | ||
Cough | 17% | 18% |
Viral respiratory infections | 3% | 4% |
Musculoskeletal | ||
Muscle pain | 8% | 8% |
Musculoskeletal pain | 6% | 6% |
Arthralgia and articular rheumatism | 2% | <1% |
Endocrine and metabolic | ||
Feeding problems (decreased or increased appetite and anorexia) | 4% | 4% |
Gastrointestinal | ||
Nausea and vomiting | 2% | 3% |
Diarrhea | 2% | 2% |
Non-site specific | ||
Temperature regulation disturbances (fever and/or chills) | 9% | 10% |
Malaise and fatigue | 8% | 8% |
aIn prophylaxis trials, symptoms associated with influenza-like illness were captured as adverse events; subjects were enrolled during a winter respiratory season during which time any symptoms that occurred were captured as adverse events. |
Postmarketing Experience
In addition to adverse events reported from clinical trials, the following events have been identified during postmarketing use of zanamivir (Relenza). Because they are reported voluntarily from a population of unknown size, estimates of frequency cannot be made. These events have been chosen for inclusion due to a combination of their seriousness, frequency of reporting, or potential causal connection to zanamivir (Relenza).
Allergic Reactions
Allergic or allergic-like reaction, including oropharyngeal edema.
Psychiatric
Delirium, including symptoms such as altered level of consciousness, confusion, abnormal behavior, delusions, hallucinations, agitation, anxiety, nightmares.
Cardiac
Arrhythmias, syncope.
Neurologic
Seizures. Vasovagal-like episodes have been reported shortly following inhalation of zanamivir.
Respiratory
Bronchospasm, dyspnea.
Skin
Facial edema; rash, including serious cutaneous reactions (e.g., erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis); urticaria.
What drugs interact with Relenza (zanamivir)?
Zanamivir is not a substrate nor does it affect cytochrome P450 (CYP) isoenzymes (CYP1A1/2, 2A6, 2C9, 2C18, 2D6, 2E1, and 3A4) in human liver microsomes. No clinically significant pharmacokinetic drug interactions are predicted based on data from in vitro studies.
The concurrent use of Relenza with live attenuated influenza vaccine (LAIV) intranasal has not been evaluated. However, because of potential interference between these products, LAIV should not be administered within 2 weeks before or 48 hours after administration of Relenza, unless medically indicated. The concern about possible interference arises from the potential for antiviral drugs to inhibit replication of live vaccine virus.
Trivalent inactivated influenza vaccine can be administered at any time relative to use of Relenza.
Summary
Relenza (zanamivir) is an inhaled antiviral drug used to treat and prevent influenza (the “flu”). Relenza decreases the spread of influenza A and B viruses, the viruses responsible for the flu. It does this by blocking the action of neuraminidase, an enzyme produced by the viruses that enables the viruses to spread from infected cells to healthy cells. Common side effects of Relenza include headaches, diarrhea, nausea, cough, vomiting, disturbance in temperature regulation, and dizziness. Drug interactions of Relenza include injections of live attenuated flu vaccine, because Relenza prevents viral replication. The Centers for Disease Control (CDC) states that pregnancy is not a contraindication for use of Relenza in pregnant women because the benefits outweigh the risks. It is unknown if Relenza is excreted in breast milk.
Multimedia: Slideshows, Images & Quizzes
-
Cold, Flu, and Cough: 13 Foods to Eat When Fighting the Flu
The best foods to eat when you have the flu soothe symptoms and help you feel better faster. Good foods to eat with the flu...
-
Cold, Fever and Flu Symptoms in Children: Medications and Home Remedies
How long does a cold last? How long is a cold contagious? Colds and fevers are some of the most common ailments in children....
-
Cold and Flu: Finding Fast Cough Relief
Remedies for coughing to relieve symptoms, thin mucus, and clear phlegm include cough syrup and honey in hot water. Use...
-
Stomach Flu: Types, Symptoms, and Treatment
Stomach flu symptoms need treatment if vomiting, diarrhea, and dehydration are severe. Stomach flu is contagious and some cases...
-
How to Get Rid of a Cold: Natural Remedies
What home remedies work to get rid of a cold fast? Many claim cold symptoms and flu symptoms can be relieved with Echinacea,...
-
Cold & Flu Quiz: Influenza vs. Common Cold
Aches? Pain? Fever? This Cold & Flu Quiz tests your knowledge on the difference between coming down with the common cold and...
-
Picture of Influenza Virus
The flu is caused by viruses that infect the respiratory tract which are divided into three types, designated A, B, and C. See a...
-
Home Remedies for Sick Children
Home remedies for sick babies, toddlers, and kids can help with things like colds, flu, cough, sore throat, stuffy nose, fever,...
-
A Cold or The Flu? How to Tell the Difference
Discover the difference between cold vs. flu symptoms. Learn the difference between cold and flu symptoms. Read about cold and...
-
Germs: Everyday Items with the Most Bacteria
Explore the germiest places you may encounter daily. Bacteria is everywhere. Learn tips to avoid germs and bacteria in public...
-
Flu Shots: 10 Facts About Flu Shots
What are the side effects of a flu shot? Who should get vaccinated? Learn the benefits and risks of vaccination for seasonal...
Related Disease Conditions
-
Flu (Influenza)
Influenza (flu) is a respiratory illness caused by a virus. Flu symptoms include fever, cough, sore throat, runny nose, headache, fatigue, and muscle aches. The flu may be prevented with an annual influenza vaccination.
-
How Long Is a Cold or Flu Contagious?
Viruses cause the common cold and the flu. Early symptoms and signs for a cold and the flu are similar, however, flu symptoms are typically more severe than cold symptoms. Cold and flu viruses are transmitted typically via coughing or sneezing.
-
Bird Flu (Avian Influenza, Avian Flu)
Bird flu (avian flu, avian influenza) infection in humans may result from contact with infected poultry. There is a vaccine to prevent human infection with the H5N1 strain of the avian flu virus.
-
COVID-19 vs. Flu vs. Cold
When you're feeling sick, it can be difficult to distinguish the symptoms of a COVID-19 infection from the symptoms of the common cold or the flu (influenza). While fever is common with the flu and COVID-19, sneezing is typically only associated with colds. Though sore throats are typical with colds, they are uncommon with COVID-19 infections and the flu.
-
Cold vs. Flu
Though the common cold and flu share many signs and symptoms, they are caused by different viruses. Signs and symptoms include sneezing, sore throat, runny nose, fatigue, and cough. Treatment options for the cold and flu are similar and focus on reducing symptoms. Doctors may prescribe antivirals/neuraminidase inhibitors for the flu.
-
Swine Flu (Swine Influenza A [H1N1 and H3N2])
Novel H1N1 influenza A virus infection (swine flu) is an infection that generally is transferred from an infected pig to a human, however there have been reported cases where infection has occured with no contact with infected pigs. Symptoms of swine flu are "flu-like" and include fever, cough, and sore throat. Treatment is generally with the antibiotics oseltamivir (Tamiflu) or zanamivir (Relenza).
-
Cold, Flu, Allergy Treatments
Before treating a cold, the flu, or allergies with over-the-counter (OTC) medications, it's important to know what's causing the symptoms, which symptoms one wishes to relieve, and the active ingredients in the OTC product. Taking products that only contain the medications needed for relieving your symptoms prevents ingestion of unnecessary medications and reduces the chances of side effects.
-
Is Swine Flu (H1N1) Contagious?
Swine flu (H1N1) is a contagious virus that spreads when an infected individual expels virus-containing droplets into the air during coughing or sneezing. Symptoms include sore throat, runny nose, fever, cough, chills, headache, fatigue, and possible vomiting and/or diarrhea. An H1N1 infection typically lasts for about a week.
Treatment & Diagnosis
- Cold & Flu FAQs
- Flu Vaccine 2000 - Why The Shortage?
- Metapneumovirus, New Cause of Flu
- Nasal Flu Vaccine for Children
- Flu: Waiting for Flu Shots, a Real Reality Show
- Flu Shot Fiasco, Critical Incident Report
- Tamiflu for Bird Flu?
- Bird Flu: Rapid Lab Test Available for Diagnosis
- Swine Flu: One New York City Pediatrician's View
- Swine Flu: How a Hospital Prepares for Patients
- Swine Flu Symptoms, Diagnosis, and Vaccination
- What to Do if You Think You Have H1N1 Swine Flu Virus
- H1N1 Swine Flu Can Infect Some Pets
- What Is Tamiflu?
- Flu Shot Side Effects
- Will a Flu Shot Prevent Pleurisy?
- Flu Shots - Next Big Influenza Outbreak
- Bird Flu: What Is Bird Flu? Should We Be Concerned?
- How Does a Person Catch Swine Flu?
- Flu: What to Do if You Get the Flu
- When to Call the Doctor for Fever, Nausea, Diarrhea, Colds, and Coughs
- Influenza A (H3N2)v: What Goes Around Comes Around
- Flu Free: How to Fend Off the Flu
Medications & Supplements

Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Professional side effects and drug interactions sections courtesy of the U.S. Food and Drug Administration.